TWI468178B - Solid preparation of solid dispersion and method for producing the same - Google Patents

Solid preparation of solid dispersion and method for producing the same Download PDF

Info

Publication number: TWI468178B
Authority: TW; Taiwan
Prior art keywords: water; solid dispersion; solid; low; drug
Prior art date: 2006-08-08

Application number

TW96129038A

Other languages

English (en)

Chinese (zh)

Other versions

TW200815034A (en

Inventor

Takafumi Hoshino

Fumie Kusaki

Naosuke Maruyama

Yuichi Nishiyama

Ikuo Fukui

Hiroshi Umezawa

Original Assignee

Shinetsu Chemical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-08

Filing date

2007-08-07

Publication date

2015-01-11

2007-08-07 Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co

2008-04-01 Publication of TW200815034A publication Critical patent/TW200815034A/zh

2015-01-11 Application granted granted Critical

2015-01-11 Publication of TWI468178B publication Critical patent/TWI468178B/zh

Links

239000007962 solid dispersion Substances 0.000 title claims abstract description 55
238000002360 preparation method Methods 0.000 title claims abstract description 45
238000004519 manufacturing process Methods 0.000 title claims abstract description 14
239000007787 solid Substances 0.000 title claims description 35
229940079593 drug Drugs 0.000 claims abstract description 57
239000003814 drug Substances 0.000 claims abstract description 57
239000000843 powder Substances 0.000 claims abstract description 53
229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims abstract description 39
229920003169 water-soluble polymer Polymers 0.000 claims abstract description 29
239000002245 particle Substances 0.000 claims abstract description 25
238000000034 method Methods 0.000 claims abstract description 18
238000004438 BET method Methods 0.000 claims abstract description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
230000008961 swelling Effects 0.000 claims description 33
229920002678 cellulose Polymers 0.000 claims description 24
239000001913 cellulose Substances 0.000 claims description 23
239000000546 pharmaceutical excipient Substances 0.000 claims description 10
238000011084 recovery Methods 0.000 claims description 9
239000003795 chemical substances by application Substances 0.000 claims description 8
238000007906 compression Methods 0.000 claims description 8
230000006835 compression Effects 0.000 claims description 8
-1 hydroxypropoxy group Chemical group 0.000 claims description 8
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
239000001863 hydroxypropyl cellulose Substances 0.000 claims description 6
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
238000006467 substitution reaction Methods 0.000 claims description 4
229920013820 alkyl cellulose Polymers 0.000 claims description 3
239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 2
229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
125000002887 hydroxy group Chemical class [H]O* 0.000 claims 1
125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
238000001035 drying Methods 0.000 abstract description 14
238000005507 spraying Methods 0.000 abstract description 4
239000006185 dispersion Substances 0.000 abstract description 3
239000007884 disintegrant Substances 0.000 abstract 3
239000007909 solid dosage form Substances 0.000 abstract 3
239000003826 tablet Substances 0.000 description 65
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 63
238000004090 dissolution Methods 0.000 description 29
239000000047 product Substances 0.000 description 21
235000011121 sodium hydroxide Nutrition 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
239000008187 granular material Substances 0.000 description 17
239000000243 solution Substances 0.000 description 15
230000000052 comparative effect Effects 0.000 description 14
229920000642 polymer Polymers 0.000 description 10
239000002904 solvent Substances 0.000 description 10
238000005886 esterification reaction Methods 0.000 description 9
239000000376 reactant Substances 0.000 description 9
238000005469 granulation Methods 0.000 description 8
230000003179 granulation Effects 0.000 description 8
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 8
229960001597 nifedipine Drugs 0.000 description 8
239000012748 slip agent Substances 0.000 description 8
239000003513 alkali Substances 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
238000005056 compaction Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 7
238000010298 pulverizing process Methods 0.000 description 7
239000002994 raw material Substances 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
229920002261 Corn starch Polymers 0.000 description 6
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
FAIIFDPAEUKBEP-UHFFFAOYSA-N Nilvadipine Chemical compound COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 FAIIFDPAEUKBEP-UHFFFAOYSA-N 0.000 description 6
239000008120 corn starch Substances 0.000 description 6
229940099112 cornstarch Drugs 0.000 description 6
239000007789 gas Substances 0.000 description 6
238000000227 grinding Methods 0.000 description 6
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 6
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 6
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 6
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 6
239000000463 material Substances 0.000 description 6
229960005366 nilvadipine Drugs 0.000 description 6
238000012360 testing method Methods 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
239000008101 lactose Substances 0.000 description 5
239000011812 mixed powder Substances 0.000 description 5
238000005406 washing Methods 0.000 description 5
238000000748 compression moulding Methods 0.000 description 4
230000007423 decrease Effects 0.000 description 4
238000007922 dissolution test Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
229920000609 methyl cellulose Polymers 0.000 description 4
239000001923 methylcellulose Substances 0.000 description 4
235000010981 methylcellulose Nutrition 0.000 description 4
239000012046 mixed solvent Substances 0.000 description 4
238000000465 moulding Methods 0.000 description 4
CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 4
238000001694 spray drying Methods 0.000 description 4
238000003756 stirring Methods 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000011324 bead Substances 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
229960000913 crospovidone Drugs 0.000 description 3
230000018044 dehydration Effects 0.000 description 3
238000006297 dehydration reaction Methods 0.000 description 3
229910052742 iron Inorganic materials 0.000 description 3
229920003145 methacrylic acid copolymer Polymers 0.000 description 3
229940117841 methacrylic acid copolymer Drugs 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 3
235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 3
WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
239000002585 base Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
229950008138 carmellose Drugs 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
229960005091 chloramphenicol Drugs 0.000 description 2
238000012937 correction Methods 0.000 description 2
239000006184 cosolvent Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
229960001031 glucose Drugs 0.000 description 2
239000007788 liquid Substances 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000002609 medium Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000006386 neutralization reaction Methods 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
229960003893 phenacetin Drugs 0.000 description 2
230000008569 process Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
230000002522 swelling effect Effects 0.000 description 2
VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241001070941 Castanea Species 0.000 description 1
235000014036 Castanea Nutrition 0.000 description 1
229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229940081734 cellulose acetate phthalate Drugs 0.000 description 1
230000008859 change Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
229960003529 diazepam Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
229960000648 digitoxin Drugs 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000012738 dissolution medium Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000000857 drug effect Effects 0.000 description 1
238000002036 drum drying Methods 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000005484 gravity Effects 0.000 description 1
DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
229960002867 griseofulvin Drugs 0.000 description 1
238000009775 high-speed stirring Methods 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
239000001341 hydroxy propyl starch Substances 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
235000013828 hydroxypropyl starch Nutrition 0.000 description 1
229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
238000009434 installation Methods 0.000 description 1
229960004130 itraconazole Drugs 0.000 description 1
239000010977 jade Substances 0.000 description 1
238000007561 laser diffraction method Methods 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
230000000873 masking effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229960002036 phenytoin Drugs 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000011085 pressure filtration Methods 0.000 description 1
239000011164 primary particle Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
238000005204 segregation Methods 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000006104 solid solution Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000010959 steel Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
238000003828 vacuum filtration Methods 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000011800 void material Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW96129038A 2006-08-08 2007-08-07 Solid preparation of solid dispersion and method for producing the same TWI468178B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006215401		2006-08-08
JP2006287859		2006-10-23

Publications (2)

Publication Number	Publication Date
TW200815034A TW200815034A (en)	2008-04-01
TWI468178B true TWI468178B (zh)	2015-01-11

Family

ID=38520550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW96129038A TWI468178B (zh)	2006-08-08	2007-08-07	Solid preparation of solid dispersion and method for producing the same

Country Status (6)

Country	Link
US (1)	US8343547B2 (de)
EP (1)	EP1886672B1 (de)
KR (1)	KR101136659B1 (de)
CN (1)	CN103070838B (de)
AT (1)	ATE555776T1 (de)
TW (1)	TWI468178B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2837639B1 (de) *	2013-08-12	2020-02-26	Shin-Etsu Chemical Co., Ltd.	Verfahren zum Entwässern von wasserhaltiger niedersubstituierter Hydroxypropylzellulose und Verfahren zur Herstellung von niedrigsubstituierter Hydroxypropylzellulose damit
CN104546666A (zh) *	2013-10-18	2015-04-29	博瑞生物医药技术(苏州)有限公司	一种非达霉素固体分散体及其制备方法
BR112018008308A2 (pt) *	2015-10-30	2018-10-30	Toray Industries	micropartícula do derivado de celulose, dispersão, método para a produção da micropartícula, micropartícula compósita e preparação
WO2017091373A1 (en) *	2015-11-25	2017-06-01	Patheon Development Services Inc.	Amorphous dispersion granules and oral dosage forms
WO2017130709A1 (ja) *	2016-01-29	2017-08-03	小林　光	固形製剤、固形製剤の製造方法及び水素発生方法
KR102469464B1 (ko)	2016-10-07	2022-11-22	신에쓰 가가꾸 고교 가부시끼가이샤	저치환도 히드록시프로필 셀룰로오스 및 그의 제조 방법, 및 고형 제제
KR102498064B1 (ko)	2016-10-07	2023-02-10	신에쓰 가가꾸 고교 가부시끼가이샤	저치환도 히드록시프로필 셀룰로오스 및 그의 제조 방법, 및 고형 제제

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07324101A (ja) *	1994-05-31	1995-12-12	Shin Etsu Chem Co Ltd	低置換度ヒドロキシプロピルセルロース、その組成物およびその錠剤
JPH10279601A (ja) *	1997-04-08	1998-10-20	Shin Etsu Chem Co Ltd	低置換度ヒドロキシプロピルセルロース粉末
EP0957112A2 (de) *	1998-05-12	1999-11-17	Shin-Etsu Chemical Co., Ltd.	Niedrigsubstituierte Hydroxypropylcellulose und Verfahren zu deren Herstellung

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3852421A (en)	1970-03-23	1974-12-03	Shinetsu Chemical Co	Excipient and shaped medicaments prepared therewith
JPS5163927A (en)	1974-11-28	1976-06-02	Shinetsu Chemical Co	Ketsugoseiryokonajozaihokaizaino seizohoho
DE3236416A1 (de) *	1982-10-01	1984-04-05	Licentia Patent-Verwaltungs-Gmbh, 6000 Frankfurt	Verfahren zur qualitaetsbeurteilung von stahloberflaechen
US5028433A (en) *	1988-11-30	1991-07-02	Banyu Pharmaceutical Co., Ltd.	Readily absorbable drug formulation of NB-818
HU209564B (en)	1991-01-30	1994-07-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing rapide tablets containing levodopa and carbidopa
DK0662320T3 (da)	1991-08-30	2001-09-24	Showa Pharm Chem Ind	Tør gelsammensætning
US5340591A (en)	1992-01-24	1994-08-23	Fujisawa Pharmaceutical Co., Ltd.	Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
DE19504832A1 (de) *	1995-02-14	1996-08-22	Basf Ag	Feste Wirkstoff-Zubereitungen
JP3001401B2 (ja)	1995-09-19	2000-01-24	信越化学工業株式会社	セルロースエーテルの粉末化方法およびセルロースエーテルの粉末化装置
AU717817B2 (en)	1996-06-06	2000-04-06	Bifodan A/S	Enteric coating, comprising alginic acid, for an oral preparation
JP3408398B2 (ja)	1997-05-09	2003-05-19	信越化学工業株式会社	低置換度ヒドロキシプロピルセルロース粉末の製造方法
JP3799134B2 (ja) *	1997-05-28	2006-07-19	ソニー株式会社	システムおよび通知方法
US6396509B1 (en) *	1998-02-21	2002-05-28	Koninklijke Philips Electronics N.V.	Attention-based interaction in a virtual environment
US6380952B1 (en) *	1998-04-07	2002-04-30	International Business Machines Corporation	System for continuous display and navigation in a virtual-reality world
US6782374B2 (en) *	1998-12-22	2004-08-24	Accenture Global Services Gmbh	System, method and article of manufacturing for a runtime program analysis tool for a simulation engine
EG23951A (en)	1999-03-25	2008-01-29	Otsuka Pharma Co Ltd	Cilostazol preparation
EP1054019A1 (de) *	1999-05-18	2000-11-22	Shin-Etsu Chemical Co., Ltd.	Niedersubstituierte Hydroxypropylcellulose
JP2001009316A (ja)	1999-06-29	2001-01-16	Shin Etsu Chem Co Ltd	パルプの粉末化方法及びセルロースエーテルの製造方法
US6680069B1 (en)	1999-11-09	2004-01-20	Shin-Etsu Chemical Co., Ltd.	Low-substituted hydroxypropyl cellulose and process for manufacturing the same
DE60110666T2 (de) *	2000-03-17	2006-02-02	Shin-Etsu Chemical Co., Ltd.	Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
KR100496749B1 (ko) *	2000-07-05	2005-06-22	아사히 가세이 가부시키가이샤	셀룰로스 분말
US7036082B1 (en) *	2000-09-21	2006-04-25	Nortel Networks Limited	Controlling communications through a virtual reality environment
US6910186B2 (en) *	2000-12-08	2005-06-21	Kyunam Kim	Graphic chatting with organizational avatars
US7009046B2 (en)	2001-12-11	2006-03-07	Shin-Etsu Chemical Co. Ltd.	Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression
WO2003063831A2 (en)	2002-02-01	2003-08-07	Pfizer Products Inc.	Immediate release dosage forms containing solid drug dispersions
US6995144B2 (en) *	2002-03-14	2006-02-07	Eisai Co., Ltd.	Nitrogen containing heterocyclic compounds and medicines containing the same
TW200404544A (en)	2002-06-17	2004-04-01	Kowa Co	Controlled release pharmaceutical composition
JP2004067606A (ja)	2002-08-08	2004-03-04	Zensei Yakuhin Kogyo Kk	イトラコナゾール経口投与製剤
KR100592511B1 (ko)	2002-12-30	2006-07-03	안경섭	벤즈이미다졸 유도체 또는 약리학적으로 허용되는 이의염을 활성물질로 하는 안정성이 강화된 방출제어형 제제및 그 제조방법
US7913176B1 (en) *	2003-03-03	2011-03-22	Aol Inc.	Applying access controls to communications with avatars
CN100563658C (zh) *	2003-11-14	2009-12-02	味之素株式会社	苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
EP1854463A4 (de)	2005-03-03	2011-03-23	Takeda Pharmaceutical	Zusammensetzung mit kontrollierter freisetzung
US8486450B2 (en)	2005-12-28	2013-07-16	Takeda Pharmaceutical Company Limited	Method of producing solid preparation disintegrating in the oral cavity
US20100226979A1 (en)	2006-03-21	2010-09-09	Jubilant Organosys Limited	Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate

2007
- 2007-08-01 US US11/888,445 patent/US8343547B2/en not_active Expired - Fee Related
- 2007-08-06 EP EP07015395A patent/EP1886672B1/de not_active Not-in-force
- 2007-08-06 AT AT07015395T patent/ATE555776T1/de active
- 2007-08-07 TW TW96129038A patent/TWI468178B/zh not_active IP Right Cessation
- 2007-08-07 KR KR1020070078998A patent/KR101136659B1/ko not_active Expired - Fee Related
- 2007-08-08 CN CN201210544516.3A patent/CN103070838B/zh not_active Expired - Fee Related

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07324101A (ja) *	1994-05-31	1995-12-12	Shin Etsu Chem Co Ltd	低置換度ヒドロキシプロピルセルロース、その組成物およびその錠剤
JPH10279601A (ja) *	1997-04-08	1998-10-20	Shin Etsu Chem Co Ltd	低置換度ヒドロキシプロピルセルロース粉末
EP0957112A2 (de) *	1998-05-12	1999-11-17	Shin-Etsu Chemical Co., Ltd.	Niedrigsubstituierte Hydroxypropylcellulose und Verfahren zu deren Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
International Journal of Pharmaceutics 197 (2000) 107-116 *

Also Published As

Publication number	Publication date
CN103070838A (zh)	2013-05-01
ATE555776T1 (de)	2012-05-15
US8343547B2 (en)	2013-01-01
EP1886672A2 (de)	2008-02-13
EP1886672B1 (de)	2012-05-02
KR20080013777A (ko)	2008-02-13
TW200815034A (en)	2008-04-01
EP1886672A3 (de)	2009-11-04
CN103070838B (zh)	2014-12-31
KR101136659B1 (ko)	2012-04-18
US20080038339A1 (en)	2008-02-14

Legal Events

Date	Code	Title	Description
2022-10-11	MM4A	Annulment or lapse of patent due to non-payment of fees

Publication	Publication Date	Title
TWI414321B (zh)	2013-11-11	Solid preparation of enteric solid dispersion and method for producing the same
TWI600665B (zh)	2017-10-01	Low-substituted hydroxypropyl cellulose powder and its production method
CN101120922B (zh)	2012-04-11	肠溶固体分散体的固体制剂及其制备方法
TWI468178B (zh)	2015-01-11	Solid preparation of solid dispersion and method for producing the same
TWI469802B (zh)	2015-01-21	Solid dispersion preparation
CA2737380C (en)	2017-04-11	Tabletting excipient based on lactose and cellulose
JP5258223B2 (ja)	2013-08-07	腸溶性固体分散体の固形製剤及びその製造方法
KR101074241B1 (ko)	2011-10-14	장용성 고체 분산체를 포함하는 고형 제제
CN107915781A (zh)	2018-04-17	羟烷基烷基纤维素、其生产方法和固体制剂
JP6318103B2 (ja)	2018-04-25	打錠用ヒドロキシアルキルアルキルセルロース及びこれを含む固形製剤
KR102518794B1 (ko)	2023-04-07	타정용 알킬셀룰로오스 및 이것을 포함하는 고형 제제
JP5258224B2 (ja)	2013-08-07	固体分散体の固形製剤及びその製造方法
CN103313703A (zh)	2013-09-18	制剂用崩解型核粒子
CA2747345C (en)	2017-05-16	Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
WO2022153246A1 (en)	2022-07-21	Solid tablet dosage form of ridinilazole
CN117462544A (zh)	2024-01-30	一种羧胺三唑固体分散体、片剂及其制备工艺
EP2590627A1 (de)	2013-05-15	Aliskiren im form einer festen dispersion